TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive Control Finally Gets A Leader–Diane Fink–With An In-House Promotion; NCI Says It Will Spend All The Program’s $34 Million March 1, 1974
TCL Archive NCI Program: reports Urges Expansion of Surveillance Program To Better Explain Trends April 30, 1999
TCL Archive “Mind Boggling” Results Reported In Trials Using 3-Drug Combination For Breast Cancer October 10, 1975
